False-positive breast biopsies cost the U.S. healthcare system approximately $2.18 billion each year, according to a study published in ClinicoEconomics and Outcomes Research.

Researchers from Hannover Medical School in Germany have developed a tablet-based symptom drawing application to provide clinicians and patients with a way to assess pain. The team published its findings May 30 in JMIR mHealth and uHealth.

President Donald Trump announced on Tuesday, May 29, that proposed tariffs on $50 billion worth of Chinese imported goods, including medical imaging equipment, are back on the table.

On Tuesday, May 29, President Donald Trump indicated the U.S. would proceed with its planned tariffs on $50 billion in Chinese imports.

An initiative to boost Scotland’s radiologist count by at least 10 percent in the midst of a national shortage “has failed,” The Herald Scotland reported, leaving cancer patients across the country without access to potentially life-saving treatments.

Patients who are nonwhite and less educated value patient portals to view clinician notes more than white and educated patients, according to a study published May 24 in the Journal of Medical Internet Research.

Pfizer gave more than $10 million to a charity for heart patients while dramatically increasing the price of one of its antiarrhythmic drugs, deflecting costs from patients and leaving Medicare with a bigger bill, the U.S. Justice Department said in a May 24 settlement statement.

Breast pain impacts more than half of all women and affects the quality of life of 41 percent of women. Healthcare resources are overutilized to treat these patients, according to a new study published in the American Journal of Roentgenology, suggesting imaging providers should pay closer attention to recommended protocols and referring physicians may need additional education.